1. Lin KW, Yancey JR. Evaluating the evidence for Choosing Wisely in primary care using the Strength of Recommendation Taxonomy (SORT). J Am Board Fam Med 2016;29:512-515.
2. Ebell M, Lin KW. Counseling women about breast cancer screening. Am Fam Physician 2016;93:652-653.
3. Raffoul M, Lin KW. Influenza vaccination for the prevention of cardiovascular disease. Am Fam Physician 2016;93:357-358.
4. Lin KW, Gostin LO. A public health framework for screening mammography: evidence-based vs politically mandated care. JAMA 2016; 315:977-978.
5. Lin KW. Should family physicians routinely screen patients for hepatitis C? No: one-time screening still has too many unanswered questions. Am Fam Physician 2016;93:17-18.
6. Lin K, O'Gurek D, Rich R, Savoy M. How to help your patients Choose Wisely. Fam Pract Manag 2015;22:28-34.
7. Raffoul M, Lin KW. Cultural competence education for health care professionals. Am Fam Physician 2015;91:523-524.
8. Koretz RL, Lin KW, Ioannidis JP, Lenzer J. Is widespread screening for hepatitis C justified? BMJ 2015;350;g7809.
9. Lin KW. What to do at well-child visits: the AAFP’s perspective. Am Fam Physician 2015;91:362-364.
10. Siwek J, Lin KW. More ways to improve health and reduce harm: Choosing Wisely phase 3. Am Fam Physician 2014;89:329.
12. Lin KW, Sieber PR, Oyer RA. The controversial prostate-specific antigen (PSA) test: a roundtable discussion of its indications and uses. J Lancaster Gen Hosp 2012;7(4):101-110.
13. Lin KW. Practice guidelines produced by subspecialists must meet higher standards. [Letter] Ann Fam Med published online November 15, 2012.
14. Lin KW. Do electronic health records improve processes and outcomes of preventive care? Am Fam Physician 2012;85:956-957.
15. Barton MB, Lin K. Screening for Ovarian Cancer: Evidence Update for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. AHRQ Publication No. 12-05165-EF3. Rockville, MD: Agency for Healthcare Research and Quality, April 2012.
16. Lin K, Croswell JM, Koenig H, Lam C, Maltz A. Prostate-specific antigen-based screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 90. AHRQ Publication No. 12-05160-EF-1. Rockville, MD: Agency for Healthcare Research and Quality, October 2011.
17. Lin KW. Challenging the conventional wisdom on colorectal and prostate cancer screening. J Lanc Gen Hosp 2010;5(3):74-77.
18. Lin K, Sharangpani R. Screening for testicular cancer: an evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2010;153:396-99.
19. Lin KW. Ways to measure and improve patient satisfaction online. The Maryland Family Doctor 2010;47(1):15.
20. Lin K. Adverse effects. Pulse: voices from the heart of medicine. May 21, 2010.
21. Lin KW, Slawson DC. Identifying and using good practice guidelines. Am Fam Physician 2009;80:67-69
22. Lin K, Lipsitz R, Miller T, Janakiraman S. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:192-99.
23. Lin K, Fajardo K. Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2008;149:W-20-W-24.
24. Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2008;148:535-43.